This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Exelixis, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Jean-Francois A Martini
Introduction
Jean-Francois A Martini is a notable inventor based in Redwood City, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the use of specific modulators to inhibit key kinases involved in cancer progression.
Latest Patents
Jean-Francois A Martini holds a patent for a method of using PI3K and MEK modulators. This invention provides methods of treating cancer with a combination of compounds that inhibit kinases, specifically targeting MEK and PI3K. His patent represents a crucial advancement in the fight against cancer, offering new therapeutic options for patients.
Career Highlights
Martini is currently associated with Exelixis, Inc., a company dedicated to developing innovative cancer therapies. His role at Exelixis allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Dana T Aftab and A Douglas Laird. Their collective expertise enhances the research environment at Exelixis, fostering innovation and development in cancer treatment.
Conclusion
Jean-Francois A Martini's work exemplifies the impact of innovative thinking in the medical field. His contributions to cancer treatment through his patent and collaboration with esteemed colleagues highlight the importance of research and development in improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile